Purwati (internist): In terms of general notability, the coverage of her patent is not high by international standards, nor is there evidence of impact of the work (other than patent filing).  FuzzyMagma ( talk ) 11:32, 11 May 2024 (UTC) [ reply ] Note:  This discussion has been included in the deletion sorting lists for the following topics: Academics and educators , Women ,  and Indonesia .  Spiderone (Talk to Spider) 11:41, 11 May 2024 (UTC) [ reply ] @ FuzzyMagma : Hello, I agree that the subject of this article has not yet gained international recognition.  However, in Indonesia, he is regarded as a prominent stem cell expert who frequently garners attention from major, reputable Indonesian mass media.  He holds the distinction of being a MURI record holder for receiving the most Intellectual Property Rights (IPR) in the Stem Cell Field in 2022, a testament to his significant contributions.  Despite the challenge of finding additional sources regarding the impact of his research, these achievements underscore his expertise and standing in the field.  He was partner of the COVID-19 Response Acceleration Task Force during Covid-19 pandemic to advancing research, particularly in investigating Drug and Stem Cell Combination Regimens in 2020.  Furthermore, his expertise is actively leveraged by Universitas Airlangga and hospitals to enhance stem cell services.  In 2019, as stated in the article, she received national recognition, being listed as an 'Indonesian Young Scientist' by the Ministry of Research, Technology, and Higher Education.  I remain guided by the notability criteria (Wikipedia:Notability).  He is quite well-known in Indonesia despite not being internationally renowned.  His notability has also been explained in the article through his career and achievements.  Rahmatdenas ( talk ) 14:16, 11 May 2024 (UTC) [ reply ] none of the sources looks reliable , with some being self-published , and the burden is on you to show that these sources are reliable, see WP:BURDEN .  As far as resources goes, this might all be a hoax as work around stem cells and COVID is highly cited, and I cannot see anything that suggests that.  PS: you mean "she" not "he" FuzzyMagma ( talk ) 14:23, 11 May 2024 (UTC) [ reply ] Delete .  No sign that she passes WP:NACADEMIC , her top research doesn't even cross 50 citations.  Allan Nonymous ( talk ) 21:27, 14 May 2024 (UTC) [ reply ] Delete .  For certain her h-factors is low, and she has no major international awards to indicate peer recognition.  What I also find disturbing is the mention of using STEM cell transplant for immuno diseases and some cancers as one of her patents.  In fact I am pretty certain that these are either close to or already being trialed in the UK by others, perhaps elsewhere as well.  There is no indication that she is involved in any of that, otherwise there would be mentions in the UK Grauniad or the New York Times in the sources.  If you have the will local patents are easy, but I have seen some local ones which would never be enforceable internationally.  Hence I end up being very unconvinced by both the article and it's defence.  Ldm1954 ( talk ) 12:40, 15 May 2024 (UTC) [ reply ] The above discussion is preserved as an archive of the debate.  Please do not modify it.  Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review ).  No further edits should be made to this page.

Discussion outcome: delete